Metriopharm Ag Is A Swiss Biotech Company Developing First In Class Auto Regulated Immune Modulators Targeting The Pathologically Dysregulated Mitochondrial Metabolism In Macrophagesmetriopharm S Platform Of Oral Small Molecules Has Demonstrated Preclinical & Clinical Efficacythree Phase Ii Studiesin Several Inflammatory And Infectious Diseases With An Excellent Safety Profile As A Monotherapymetriopharm S Lead Candidate Mp1032 Produces Therapeutic Effects Similar To Corticosteroidscortisone Based Therapeutics But Without Serious Side Effectsmp1032 Has Demonstrated Synergistic Supra Additive Effects In Combination With An Ultra Low Dose10Of The Normal Doseof Corticosteroidsdemonstrating The Potential To Create A New Class Ofsuper Corticosteroidsthat Are More Effective And Have No Serious Side Effectsfor More Than 60 Yearsthere Have Been No Major Advances In Achieving Such Corticosteroid Sparing Therapy And Thereby Reducing Corticosteroid Specific Side Effects In Additionmp1032 Has Demonstrated A Broad Host Directed Antiviral And Antibacterial Activity In Preclinical Studiesthe Company Is Headquartered In Zurich And Has A Subsidiary For R&D Activities In Berlin
| Company Name | Metriopharm Ag |
| Country |
Switzerland
|
| Address | N/A |
| Telephone | N/A |
| N/A |
United States